Chemoinformaics analysis of trans,trans-2,8-Decadiene
| Molecular Weight | 138.254 | nRot | 5 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 2 |
| Exact Molecular Weight | 138.141 | nRing | 0 |
| Solubility: LogS | -4.225 | nHRing | 0 |
| Solubility: LogP | 4.095 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.7023 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.401 |
| Synth | 2.686 |
| Natural Product Likeliness | 1.373 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.012 |
| CACO-2 | -4.481 |
| MDCK | 0.0000234 |
| BBB | 0.21 |
| PPB | 0.998996 |
| VDSS | 5.666 |
| FU | 0.0229256 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.548 |
| CYP2c19-inh | 0.462 |
| CYP2c19-sub | 0.224 |
| CYP2c9-inh | 0.139 |
| CYP2c9-sub | 0.915 |
| CYP2d6-inh | 0.395 |
| CYP2d6-sub | 0.615 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.129 |
| CL | 5.189 |
| T12 | 0.355 |
| hERG | 0.014 |
| Ames | 0.003 |
| ROA | 0.005 |
| SkinSen | 0.936 |
| Carcinogencity | 0.037 |
| EI | 0.987 |
| Respiratory | 0.09 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.935092 |